This content is machine translated New perspectives for the optimization of cancer immunotherapy Nanoparticle-mediated intratumoral gene editing of PD-L1 and galectin-9 Immune checkpoint inhibitors (ICI) have revolutionized oncological therapy, but many patients do not respond or only respond inadequately to this form of treatment. Resistance mechanisms such as the overexpression of...…
